Related Experiment Video
Updated: May 5, 2026

Unravelling the Function of a Bacterial Effector from a Non-cultivable Plant Pathogen Using a Yeast Two-hybrid Screen
Published on: January 20, 2017
'Drugs from bugs': bacterial effector proteins as promising biological (immune-) therapeutics
Christian Rüter1, Philip R Hardwidge
1Center for Molecular Biology of Inflammation (ZMBE), Institute of Infectiology, University of Münster, Münster, Germany.
Abstract:
Immune system malfunctions cause many of the most severe human diseases. The immune system has evolved primarily to control bacterial, viral, fungal, and parasitic infections. In turn, over millions of years of coevolution, microbial pathogens have evolved various mechanisms to control and modulate the host immune system for their own benefit and survival. For example, many bacterial pathogens use virulence proteins to modulate and exploit target cell mechanisms. Our understanding of these bacterial strategies opens novel possibilities to exploit 'microbial knowledge' to control excessive immune reactions. Gaining access to strategies of microbial pathogens could lead to potentially huge benefits for the therapy of inflammatory diseases. Most work on bacterial pathogen effector proteins has the long-term aim of neutralizing the infectious capabilities of the pathogen. However, attenuated pathogens and microbial products have been used for over a century with overwhelming success in the form of vaccines to induce specific immune responses that protect against the respective infectious diseases. In this review, we focus on bacterial effector and virulence proteins capable of modulating and suppressing distinct signaling pathways with potentially desirable immune-modulating effects for treating unrelated inflammatory diseases.
Insights
Bacterial virulence proteins can be harnessed to control immune system overreactions. This microbial knowledge offers new therapeutic strategies for inflammatory diseases by modulating immune responses.
Area of Science:
- Immunology
- Microbiology
- Pathogen-Host Interactions
Background:
- Immune system malfunctions contribute to severe human diseases.
- Microbial pathogens have evolved mechanisms to modulate host immunity for survival.
- Bacterial virulence proteins exploit host cell functions.
Purpose of the Study:
- To explore the potential of bacterial effector and virulence proteins in treating inflammatory diseases.
- To investigate how microbial strategies can be repurposed for immune modulation.
- To review bacterial proteins that suppress distinct signaling pathways for therapeutic benefit.
Main Methods:
- Review of scientific literature on bacterial effector and virulence proteins.
- Analysis of microbial strategies for modulating host immune responses.
- Examination of signaling pathways targeted by bacterial proteins.
Main Results:
- Bacterial pathogens utilize effector proteins to manipulate host cell mechanisms.
- Understanding these bacterial strategies provides a basis for novel immunomodulatory therapies.
- Specific bacterial proteins can suppress immune signaling pathways.
Conclusions:
- Repurposing bacterial virulence factors offers a promising avenue for treating inflammatory diseases.
- Exploiting 'microbial knowledge' can lead to new therapeutic approaches for immune dysregulation.
- Bacterial effector proteins hold potential for developing treatments for conditions beyond infectious diseases.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Biological Methods for Microbial Control
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Transduction
Bacterial Toxins
Gene Regulation in Microbial Communities: Quorum Sensing

